The mechanism by which muscarinic receptors internalize upon agonist exposure is poorly understood. To determine the endocytic pathways responsible for muscarinic receptor internalization, we have stably transfected human embryonic kidney (HEK 293) cells with the Hm1 (human muscarinic subtype 1) receptor tagged at the amino terminus with the epitope EYMPME. The subcellular location of the receptor was visualized by immunofluorescence confocal microscopy and quantified with the use of binding studies. The receptor redistributed into intracellular compartments following agonist treatment. This process was reversible upon removal of agonist and inhibited by antagonist. Acid treatment of the cells, which disrupts internalization via clathrin-coated vesicles, inhibited carbachol-stimulated internalization. Phorbol 12-myristate 13-acetate, on the other hand, which inhibits caveolae-mediated endocytosis, had no effect on carbachol-induced endocytosis. Double-labeling confocal microscopy was used to characterize the intracellular vesicles containing Hm1 receptor following agonist treatment. The Hm1 receptor was shown to be colocalized with clathrin and ␣-adaptin, a subunit of the AP2 adaptor protein which links endocytosed proteins with clathrin in the intracellular vesicles. In addition, endosomes containing Hm1 also contained the transferrin receptor, which internalizes via clathrin-coated vesicles. In contrast, caveolin, the protein that comprises caveolae, did not colocalize with Hm1 in intracellular vesicles following agonist treatment, indicating that caveolae are not involved in the agonist-induced internalization of Hm1. These results indicate that agonist-induced internalization of the Hm1 receptor occurs via clathrin-coated vesicles in HEK cells.Upon agonist treatment, many cell surface receptors undergo endocytosis into compartments inaccessible to extracellular ligands. This process is known as receptor internalization. The mechanism of internalization and its role in receptor regulation and function are largely unknown. Internalization may be a possible mechanism of receptor desensitization (i.e. reduction in agonist-induced activity), or alternatively, as recently suggested by Pippig et al.(1), resensitization. The endocytosed receptors may be either recycled back to the cell surface (2) or transported to lysosomes where receptors are subsequently degraded (2), a process known as receptor downregulation.Cell surface proteins may internalize into clathrin-coated vesicles (3), caveolae (4), or noncoated vesicles (5, 6). Little is known about the mechanism of internalization for the family of G protein-coupled receptors. Studies thus far suggest that the mechanism may vary with the receptor type. Raposo et al. (7) showed that noncoated vesicles appear to be involved in the endocytosis of muscarinic receptors in CCL137 fibroblast cells. On the other hand, Silva et al. (8) have shown muscarinic receptor activity in purified clathrin-coated vesicles from bovine brain. Using electron microscopy,  2 -adrenorecep...